Some membrane interactions with bepridil, a new antianginal agent.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology*; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001001:Anura; D001596:Benzylamines / Q000494:pharmacology*; D002122:Calcium Chloride / Q000494:pharmacology; D002319:Cardiovascular System / Q000187:drug effects* / Q000648:ultrastructure; D002462:Cell Membrane / Q000187:drug effects; D004347:Drug Interactions; D004594:Electrophysiology; D005260:Female; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D010210:Papillary Muscles / Q000187:drug effects; D011189:Potassium Chloride / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology*; D011817:Rabbits; D011893:Rana esculenta
D000319:Adrenergic beta-Antagonists; D000588:Amines; D000889:Anti-Arrhythmia Agents; D001596:Benzylamines; D011759:Pyrrolidines; D011189:Potassium Chloride; D007545:Isoproterenol; D002122:Calcium Chloride